J Allergy Clin Immunol Pract. 2019;7(8):2851-2853.e2.
Carbonic anhydrase inhibitor-induced Stevens-Johnson syndrome/toxic epidermal necrolysis leads to extensive cutaneous involvement.
제1저자 김수정 · 교신저자 강혜련, 이종명
소속 (9)
- Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Korea.
- Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Division of Medicine, Nepean Hospital, Sydney, New South Wales, Australia.
- Drug Safety Monitoring Center, Seoul National University Hospital, Seoul, Korea.
- Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Pusan National University School of Medicine, Pusan, Korea.
- Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea.
- Drug Safety Monitoring Center, Seoul National University Hospital, Seoul, Korea; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. Electronic address: helenmed@snu.ac.kr.
- Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Korea. Electronic address: jomlee@knu.ac.kr.
Comment · 정정
그 밖의 정보
- 출판 형태
- Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
- 저널
- The journal of allergy and clinical immunology. In practice · eISSN 2213-2201
- 전자 출판
- 2019-05-22
- MeSH
- Acetazolamide / adverse effects · Adult · Aged · Carbonic Anhydrase Inhibitors / adverse effects · Female · Humans · Male · Methazolamide / adverse effects · Middle Aged · Severity of Illness Index · Stevens-Johnson Syndrome / etiology
- Substances
- Carbonic Anhydrase Inhibitors · Acetazolamide · Methazolamide